Form 4: Keysight Technologies Director Holthaus Acquires Shares Through RSU Vesting

Sentiment:

SEC Form 4 Filing


Michelle Holthaus, a director at Keysight Technologies, acquired 1,589 shares of common stock through the vesting of restricted stock units (RSUs) on March 21, 2025.

Summary

  • On March 21, 2025, Michelle Holthaus, a director of Keysight Technologies, Inc., acquired 1,589 shares of common stock.
  • This acquisition resulted from the vesting of restricted stock units (RSUs) granted under the 2014 Equity and Incentive Compensation Plan.
  • The RSUs vested immediately at a price of $0.
  • Following the transaction, Holthaus directly owns 7,613 shares of Keysight Technologies common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to executive compensation. The director increasing their holdings is a mildly positive signal.

Positives

  • The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are routinely monitored and reported to the SEC. This transaction reflects standard equity compensation practices.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment due to the director increasing their stake in the company.

Key Dates

DateDescription
03/21/2025Date of the transaction: Michelle Holthaus acquired shares through RSU vesting.
03/25/2025Date of signature on the Form 4 filing.

Keywords

Keysight Technologies, Holthaus, Director, RSU, Stock Acquisition, Beneficial Ownership, Form 4, Securities, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.